Obermatt
See Similar Stocks →

medmix

SWX:MEDX · CH1129677105
Health Care Equipment & SuppliesSmall

360

54
EV / EBIT32
Price / Owner Earnings19
Owner Earnings Yield78
Dividend Yield100
Price/Sales87
EV / Gross Profit53
Price/Book89
Return on Capital65
Cash Return on Capital74
Return on Equity67
EBIT Margin65
Gross Profitability14
Cash Conversion95
Accruals47
Owner Earnings Margin72
Sales growth24
Profit Growth20
Long-Term EPS Growth49
Reinvestment66
Price momentum33
Debt load19
Refinancing16
Debt Payback21
Liquidity14
Analyst ratings100
Opinion Changes50
Price Target Upside83
Market mood21
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

medmix clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeSWX
Founded2021
Employees512
ISINCH1129677105
Last UpdateApr 2, 2026
Indices
SPI (Switzerland)
Themes
Women's HealthOsteoporosisDiabetesInjection MoldingDentistrySurgeryBiomedical EngineeringHealth CareManufacturingMedicalMedical Device

Description

medmix AG is a company domiciled in Switzerland that stands as a global market leader in high-precision delivery devices across healthcare, consumer, and industrial sectors. Business Segments This segment is having various segment such as Healthcar…

Analysis

Middle-of-the-road

medmix AG sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is fair. The owner-earnings multiple stands at 21.9×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
31
2023202420252026

All-time high

89

Dec 2025

All-time low

5

Jan 2023

Average rank

43

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
87
81
70
51
Price/Earnings
38
61
66
49
Price/Book
89
91
92
36
Dividend Yield
100
100
99
97
Value (overall)
97
98
99
99

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare medmix with its peers
Smith & Nephew
LSE:SN.
86
CountryUK
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Ypsomed
SWX:YPSN
29
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Coltene
SWX:CLTN
64
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Steris
NYQ:STE
63
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
DiaSorin
MIL:DIA
34
CountryItaly
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Coloplast
CPH:COLO B
39
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →